Epirubicin

Epirubicin is a chemotherapy medication used to treat a variety of cancers, including breast, ovarian, stomach, bladder, and lung cancers. It belongs to a class of drugs called anthracyclines, which work by interfering with the genetic material of cancer cells, preventing them from dividing and growing. Epirubicin is usually given as an injection into a vein (intravenously) in combination with other chemotherapy medications. Common side effects include nausea, vomiting, fatigue, and hair loss.

Epirubicin is a chemotherapy medication used to treat certain types of cancer [MedlinePlus]. Here's a breakdown of its key aspects:

Type of drug: Anthracycline antibiotic [Wikipedia]

Function: Epirubicin works by interfering with the DNA of cancer cells, hindering their growth and division [National Cancer Institute].

Treatment: Epirubicin is primarily used for breast cancer, often given in combination with other chemotherapy drugs after surgery to remove the tumor [Cancer Research UK].

Administration: It is administered intravenously (through a vein) by a healthcare professional in a medical setting [MedlinePlus].

Important things to know:

  • Epirubicin can have serious side effects, including heart problems, low blood cell counts, and increased risk of infection [MedlinePlus].
  • It is not suitable for everyone, and pregnancy and breastfeeding are contraindications [MedlinePlus].

Here are some resources for further information:

Disclaimer: I am unable to provide medical advice. If you have any questions about epirubicin or its use in relation to a specific condition, please consult a doctor.

Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01D - Cytotoxic antibiotics and related substances
L01DB Anthracyclines and related substances
External Links